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SUMMARY
It has been proposed that helminth infection may be particu-
larly detrimental during pregnancy, through adverse effects
on maternal anaemia and on birth outcomes, and that
anthelminthic treatment during pregnancy will therefore be
particularly beneficial. However, the few treatment trials that
have been conducted have given, but little support to this
notion and further trials in settings of nutritional stress are
needed. It has also been proposed that prenatal exposure to
helminth infection has an important effect on the development
of the foetal immune response. There is evidence that this
may impact, long-term, upon responses to helminth and
nonhelminth antigens, and to allergens. Exposure to helm-
inths in utero may also have nonspecific effects that may
modify the offsprings susceptibility to diseases mediated by
inflammation, including metabolic disorders. The mechanisms
of such effects are not known, but they deserve to be explored
as current epidemiological findings suggest the possibility of
primary prevention for inflammatory conditions such as
allergy, through intervention during pregnancy.
Keywords allergy, anaemia, birthweight, helminth, offspring,
pregnancy
INTRODUCTION
Helminth infections are highly prevalent. In 2006, it was
estimated that over a billion people were infected with one
or more species of soil-transmitted helminth (1), while 200
million were infected with schistosomes (2). The preva-
lence of hookworm tends to increase with age (3) and,
although the intensity of schistosomiasis declines with age,
the prevalence remains high among young adults in ende-
mic communities (4). Thus, in endemic settings, there is a
high burden of helminth infection among pregnant
women, a group already at increased risk from malaria,
and susceptible to anaemia and to nutritional stress (5–8).
Implications for the mother and foetus include possible
physiological effects on haemoglobin levels and on foetal
growth and development, and possible immunological
effects on both mother and foetus. This review will exam-
ine current evidence for such effects, focusing mainly on
the latter, and discussing possible mechanisms for some of
the immunological effects that have been observed.
Observational studies on the effects of helminth infec-
tions in humans are fraught with strong potential for both
measured and unmeasured confounding, as helminths occur
in the most disadvantaged communities alongside poverty,
lack of education and malnutrition. Helminth-infected preg-
nant women are likely to be younger, less educated and of
lower socio-economic status than uninfected women (5) –
all factors that may impact upon nutrition and upon health-
seeking behaviour (importantly, uptake of iron and folate
supplements, preventive treatment for malaria and use of
bed nets) for themselves and their infants. They may come
from different ethnic backgrounds and live in different envi-
ronments, compared with uninfected women (5), and these
factors may influence customs or behaviour, and exposure
of themselves and their infants to helminths and other infec-
tions. Co-exposure of the foetus or infant to malaria may be
more common for environmental reasons, or because of
immunomodulating effects of helminths (9, 10). Random-
ized clinical trials of anthelminthic treatment should help to
address this and to identify reversible effects directly caused
by helminths.
ANTHELMINTHIC TREATMENT DURING
PREGNANCY
Historically, pregnant and breastfeeding women have often
been excluded from the treatment for helminths, due to
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concern about possible adverse effects of the drugs on the
developing foetus. However, in 1994, the World Health
Organization (WHO) recommended the treatment of preg-
nant women for hookworm, because of concern about
hookworm-induced anaemia (11). Further, in 2002, a WHO
informal consultation recommended the use of praziquantel
during pregnancy and lactation, and that in schistosomia-
sis-endemic settings, all girls and women of child-bearing
age should be included in praziquantel mass drug adminis-
tration programmes (12). It was hoped that implementation
of these recommendations would result in benefits including
reduced maternal anaemia, increased birthweight and
reduced perinatal and infant mortality. Neither of these
recommendations was based on evidence of benefit or safety
from controlled trials, and in the case of praziquantel, a
subsequent WHO Scientific Working Group, held in 2006,
called for such trials to be conducted (13). However, only a
very small number of anthelminthic trials have yet been
conducted among pregnant women (14–22) (Table 1), and
taken together, the results are, as yet, inconclusive.
PHYSIOLOGICAL EFFECTS OF HELMINTHS IN
PREGNANCY
There is substantial evidence from studies in human sub-
jects that certain species of helminth infection during preg-
nancy are associated with maternal anaemia, as reviewed
by Brooker and colleagues in 2008 (23), and observed in
several subsequent studies (24–27). It is likely that heavy
intensities of hookworm and Trichuris trichiura are partic-
ularly important (28). However, only two of five trials
assessing this outcome have shown a benefit of treatment
for soil-transmitted helminths during pregnancy (Table 1)
(17, 18). In a trial setting, it is almost imperative to pro-
vide adequate iron and folate supplementation, and (where
relevant) presumptive treatment for malaria during preg-
nancy, as standard of care during pregnancy. This may
override some of the potential benefits of anthelminthics:
Torlesse and colleagues found greater benefit of haemati-
nic supplementation than of albendazole in a hookworm-
endemic region of Sierra Leone (18).
Studies in mice suggest that maternal worm infections
influence foetal linear growth and the growth of lymphoid
tissues and bone (29, 30). There are also observational
studies in human subjects suggesting that certain maternal
helminth infections adversely affect birthweight and peri-
natal and infant mortality and that anthelminthics during
pregnancy may be beneficial for these outcomes (31–35)
[reviewed by Freidman (35) and Imhoff-Kunsch (36)], but
trials to date have failed to confirm that these associations
are causal by showing a benefit of treatment (Table 1).
Anaemia, itself, is an important cause of adverse birth
outcomes (37–39), and if effects of helminths on anaemia
are obscured by supplementation with haematinics this
may also obscure possible benefits of anthelminthics medi-
ated by reductions in anaemia (34).
If the hypothesis that anthelminthic treatment during
pregnancy can have important benefits for maternal and
infant birth outcomes is to be rigorously tested, and the
policy of routine anthelminthic treatment during preg-
nancy is to be validated, large trials are still needed in a
range of settings. It may be that anthelminthics will be
found most useful in settings in which anaemia is preva-
lent, and where there is nutritional stress and limited
access to haematinic supplementation. In such settings,
single dose benzimidazoles, [which are easy to administer
and have been highly effective against hookworm in most
trials to date (15, 16, 18, 19)] may have benefits for birth
outcomes. No trials have yet demonstrated benefits of
praziquantel treatment during pregnancy for maternal
anaemia or for birth outcomes, but a further placebo-con-
trolled trial of praziquantel treatment for Schistosoma
japonicum during pregnancy is in progress and scheduled
for completion this year (40). This will be of particular
interest because S. japonicum has been shown to be associ-
ated with inflammation in maternal, placental and foetal
tissues (41), and studies in vitro suggest that exposure of
trophoblast cells to S. japonicum egg antigen may result in
impaired placentation (42).
EFFECTS OF PREGNANCY ON SUSCEPTIBILITY
TO HELMINTHS AND ON THE RESPONSE TO
THEIR TREATMENT
Pregnancy results in major hormonal and nutritional
changes, and in immunological changes allowing successful
allograft retention (43–45). In mammals other than humans,
there is a well-recognized increase in susceptibility to
helminths, or at least to helminth egg production, around
parturition. Immune modulation resulting from hormonal
changes (such as a reduction in circulating cortisol) (46),
or nutritional changes, such as protein deficiency (47)
may contribute to this effect. In humans, data are conflict-
ing, with studies showing increased (7) or similar (48)
helminth egg counts between pregnant and nonpregnant
women.
Studies in mice also suggest that pregnancy is associated
with increased schistosome-induced pathology, related to
reduced parasite-specific interferon (IFN)-c but increased
interleukin (IL)-4 production (49). If similar effects were
demonstrated in humans, this would be a further strong argu-
ment for emphasizing schistosomiasis treatment in young,
and pregnant, women. In the Entebbe Mother and Baby
Study (EMaBS), a trial of albendazole and praziquantel
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among pregnant women in Uganda (50), we examined effects
of pregnancy on the immune response to schistosomiasis
by comparing responses during pregnancy and after delivery
in placebo recipients. Interleukin-2, IL-4 and IL-10 responses
to schistosome worm and egg antigens were similar during
pregnancy and after delivery, whereas IFN-c, IL-5 and IL-13
responses increased after delivery, suggesting that pregnancy
in humans is indeed associated with a modified profile of
antischistosome cellular responses (51). Antischistosome
antibody levels were also lower during pregnancy (52). Fur-
ther studies to investigate whether these immunological dif-
ferences are associated with differences in the progression of
pathology would be justified.
Treatment of schistosomiasis with praziquantel in non-
pregnant human subjects is associated with release of
worm antigen into the blood stream and with a boost in
cellular and antibody responses to worm and egg antigen
(53). We observed a similar, but smaller boost in responses
following treatment during pregnancy, when compared to
treatment after delivery (51, 52). This may be important
for several reasons. First, the immune response is thought
to synergize with the direct effects of praziquantel, helping
to kill the parasites (54). A reduced boost might mean
that treatment in pregnancy was less effective. However,
we found no difference in egg reduction following treat-
ment during pregnancy compared with treatment after
delivery in our study (51). Second, the sudden immunolog-
ical changes following treatment might have implications
for the success of the pregnancy. Successful pregnancies
are associated with a placental microenvironment that is
dominated by a type two cytokine milieu, characterized by
increased production of IL-4 and IL-10, and decreased
production of IFNc and IL-2 (55). Animal models of
pregnancy have shown that increased systemic and placen-
tal IFNc and TNFa levels are associated with poor preg-
nancy outcomes (56, 57). Reassuringly, in EMaBS,
praziquantel treatment of Schistosoma mansoni during
pregnancy was not associated with an increased rate of
miscarriage or still birth (19). However, the number of
women with schistosomiasis in the study was fairly small
(458), so its power to detect differences in these rates was
limited. Vigilance regarding birth outcomes will be impor-
tant as the 2002 WHO recommendations (12), to use pra-
ziquantel during pregnancy and lactation, are more widely
implemented.
IMMUNOLOGICAL EFFECTS OF HELMINTHS
ON PREGNANT WOMEN
Helminth infections modulate the host immune response
through a variety of mechanisms (58). These allow long-term
survival of the parasite within the host, while minimizing
damage to host tissues. They also have implications that may
be important during pregnancy.
First, they may impact upon susceptibility to heterolo-
gous infections. Effects on susceptibility to malaria might
be especially relevant during pregnancy, given its adverse
impact on pregnancy outcomes (59). Positive associations
between hookworm and malaria have been reported (9,
60, 61), while S. haematobium and Ascaris lumbricoides
have been associated with lower malaria parasite densities
(60) and lower malaria risk (61), respectively. While these
associations might be confounded by environmental and
behavioural factors, measured confounders failed to
explain the positive hookworm malaria and Mansonella
malaria associations observed in our study (9), and immu-
nological mechanisms are also possible.
Second, they may impact upon maternal metabolism –
for example glucose metabolism (62). A recent study in
mice showed that classical activation of macrophages
in adipose tissue (favouring inflammatory immune
responses) was associated with glucose intolerance, while
alternative activation was associated with enhanced glu-
cose tolerance. Eosinophils in adipose tissue were shown
to be a key source of IL-4 for the induction of alterna-
tively activated macrophages, and eosinophils induced by
helminth infection were shown to produce a sustained
improvement in glucose tolerance (62). Similar effects in
humans might be beneficial in relation to gestational
diabetes.
IMMUNOLOGICAL EFFECTS OF HELMINTHS
DURING PREGNANCY ON THE FOETUS
Arguably, the most important potential impact of worm
infections during pregnancy is upon long-term outcomes
in the offspring.
Effects on helminth-specific responses
There is considerable evidence from studies in both animal
models (63–65) and humans (65–70) that in utero exposure
to helminths can influence susceptibility to the same hel-
minth species later in life. For example, in 1991, Lammie
and colleagues, working in an area endemic for bancrof-
tian filariasis, showed that maternal, but not paternal, fi-
larial infection was associated with childhood infection
and that children of infected mothers had reduced cellular
responses to microfilariae compared with children of unin-
fected mothers (66). Other studies supported this result
(67). Subsequently, it was shown that children of infected
mothers who were sensitized in utero to filarial antigen
showed similar immunological and clinical outcomes to
unexposed infants, but that children who were exposed
© 2014 The Authors. Parasite Immunology Published by John Wiley & Sons Ltd., Parasite Immunology, 36, 328–337 331
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in utero and not sensitized (suggesting the acquisition of
tolerance) were slower to develop detectable cellular
responses and more likely to become microfilaraemic than
either sensitized or unexposed infants (71, 72). These
results suggest an immunological explanation for the epi-
demiological observations. There is evidence for similar
effects of intrauterine exposure in humans for onchocercia-
sis (69), schistosomiasis (70) and soil-transmitted helminth
infection (68). While increasing susceptibility, the tolero-
genic effects of prenatal exposure may reduce inflamma-
tion-induced pathology, resulting in an improved outcome
for both helminth and host.
Effects on responses to heterologous vaccines and
infections
Observational studies have also suggested that exposure to
worm infections during pregnancy can alter the offsprings
response to unrelated antigens, including vaccines, infec-
tious diseases and allergens. A study in Kenya found that
infants exposed and sensitized to schistosomiasis and filar-
ial worms in utero showed a Th2 bias in their immune
responses to BCG vaccine, while infants who were exposed
but not sensitized showed a Th1 profile of response (73).
Such an effect might contribute to explaining the poor
efficacy of BCG immunization in tropical developing
countries – one of the settings in which protection against
tuberculosis is most needed (74, 75). In the EMaBS
cohort, in which we compared responses following BCG
and tetanus immunization in infants of helminth-infected
and helminth-uninfected women, we did not observe
effects on the infant Th1 or Th2 response to mycobacte-
rial antigens, but treatment with albendazole reduced Th2
responses to tetanus toxoid among the infants of mothers
with hookworm (22). Why was this effect seen for the
response to tetanus immunization, but not for the
response to BCG? One possibility is that concurrent pre-
natal exposure to helminths and to the heterologous anti-
gen of interest may be important for the helminth effects.
EMaBS women received tetanus immunization during
pregnancy, providing a potential opportunity for exposure
of the foetus to this antigen (76); indeed the infant cyto-
kine response to tetanus immunization increased with the
number of doses that the mother received during preg-
nancy, suggesting that prenatal priming of the infant anti-
tetanus response had occurred (77). We also found that
infants of mothers with M. perstans infection had elevated
IL-10 responses to both BCG-related and tetanus antigens,
but these associations were seen only among infants of
mothers who received no albendazole, suggesting that pre-
natal exposure to albendazole, or to its effects on maternal
infections, blocked the ability of maternal M. perstans to
promote regulatory responses to heterologous antigens in
the infants (77).
Besides tuberculosis, HIV infection and malaria are
among the most important co-infections in helminth-ende-
mic settings, and there is considerable controversy as to the
effects of helminths on susceptibility to both (78). Prenatal
exposure to maternal helminths has been postulated to
increase the risk of vertical HIV transmission by activation
of foetal lymphocytes, increasing their susceptibility to
HIV infection. A small observational study in Kenya
(among 44 HIV-exposed infants, 13 of whom were HIV
infected) supported this hypothesis with an odds ratio,
adjusted for maternal malaria [aOR (95% confidence inter-
val)] of 73 (24–337) for any maternal helminth vs. none
(79). In fact, the association was prominent among infants
of mothers with filariasis, but not for other helminth spe-
cies. In EMaBS, we studied the association between vertical
HIV transmission and maternal helminth infection among
203 HIV-exposed babies (34 HIV-infected), and there was
no statistically significant association with helminth infec-
tion (aOR for all helminths combined, adjusted for the use
of nevirapine for prevention of mother-to-child HIV trans-
mission and for vaginal delivery vs. Caesarian section, 223
(086–579); K. Jacquline, M.E. Alison, unpublished data).
However, anthelminthic treatment during pregnancy
showed no benefit for this outcome (22); thus, no firm con-
clusion can yet be reached as to the effects of maternal
helminths on vertical HIV transmission.
In EMaBS, we also investigated associations between
maternal helminth and maternal malaria infection and
infant susceptibility to malaria. We found that maternal
worm infections, including hookworm, M. perstans and
S. mansoni were associated with increased risk of malaria
incidence in the offspring (10). These associations per-
sisted after adjusting for potential confounders (maternal
age, education, parity, net ownership, socio-economic sta-
tus, maternal malaria and human immunodeficiency virus
infections, and location of residence) and after stratifying
for maternal malaria infection status. In fact, there was a
suggestion that the effect was stronger among infants of
mothers who had malaria during pregnancy, again sug-
gesting that concurrent exposure to maternal malaria and
to maternal helminths might be important for helminth-
induced effects on the offsprings response to malaria, as
discussed above in relation to tetanus immunization.
Effects on allergy-related disease outcomes
The most striking findings of EMaBS was that maternal
albendazole during pregnancy was associated with an
increased incidence of infantile eczema (20) and of eczema
in the first 5 years of life (21). This effect was not confined
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to the infants of mothers with susceptible worm infections
(hookworm, Ascaris, Trichuris and Strongyloides), so the
mechanism of the effect of albendazole was not clear. How-
ever, maternal hookworm showed a significant inverse asso-
ciation with eczema in childhood, which increased with
intensity (80), and maternal hookworm modified the effect
of classical risk factors for childhood eczema, including
maternal history of eczema and childhood atopy
(H. Mpairwe, J. Ndibazza, E.L. Webb, M. Nampijja,
L. Muhangi, B. Apule, S. Lule, H. Akurut, D. Kizito,
M. Kakande, F.M. Jones, C.M. Fitzsimmons, M. Muwanga,
L.C. Rodrigues, D.W. Dunne, A.M. Elliott, unpublished
data). Maternal treatment with praziquantel was associated
with an increased incidence of infantile eczema among infants
whose mothers were infected with S. mansoni during preg-
nancy (20). Together, these findings strongly suggest that pre-
natal exposure to maternal helminth infection protects
against infantile eczema and against the adverse effects of
other exposures on this outcome. Whether this effect persists
into later childhood, and influences risk of asthma, is cur-
rently under investigation.
MECHANISMS BY WHICH MATERNAL
HELMINTH INFECTION MIGHT INFLUENCE
OUTCOMES IN THE FOETUS
The mechanisms by which maternal helminth infection
can influence outcomes in the foetus are not known.
Investigation of these mechanisms might shed important
light on the development on the infant immune response
and inform the development of possible interventions for
the primary prevention of immunologically mediated
conditions, such as allergy (81). Some possible mecha-
nisms are summarized in Figure 1 and discussed below.
Foetal exposure and sensitization to foreign antigens
It is clear that the human foetus can become sensitized to
parasite (73, 82–88) and vaccine antigens (76) in utero, and
at first sight, this is surprising as most macromolecules
and immune complexes in the maternal circulation are
broken down by macrophages in the trophoblast, provid-
ing amino acids for the growth of the placenta and foetus
and preventing transfer to the foetal circulation (89).
However, filarial (87) and schistosome (90–92) antigens
have been detected in cord blood in humans. Similarly,
there is evidence that tetanus toxoid (93) and malaria anti-
gen (94) can cross the placenta. Studies in mice also sug-
gest that mycobacterial antigen can cross the placenta
(95), and although there are differences in placentation
between mice and humans, there is evidence of prenatal
sensitization of the human foetus to mycobacterial anti-
gens in utero (73). How such antigens cross the placenta is
not known. One possibility is that the antigens are trans-
ported bound to IgG antibody, protected by the foetal
immunoglobulin G receptor (FcRn): this is supported by
studies showing that the transfer of tetanus toxoid, or of
malaria antigen, is dependent upon the presence or con-
centration of specific antibody in maternal blood (94), but
the precise process of transfer is not fully understood.
With regard to helminth-specific immune responses, epi-
demiological evidence discussed above suggests that in utero
Figure 1 Possible mechanisms by which maternal helminth infections might influence foetal immunological development.
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sensitization results in down-regulated responses among
the offspring, on encountering the homologous antigen.
As reviewed by Dauby and colleagues (96), this may be due
to a bias in the foetal and neonatal immune response
towards the development T-regulatory and T-helper (Th)17
responses, rather than Th1 responses. The effects of hel-
minth exposure might be analogous to findings for effects
of placental malaria: in vitro depletion of CD4 + CD25hi
regulatory T cells in cord blood demonstrated their contri-
bution to suppression of neonatal responses to malaria
antigens in malaria-exposed infants (97).
Transfer of antigen-specific idiotype antibodies across
the placenta
In addition to the possibility that antibodies facilitate the
transfer of antigen across the placenta, there is evidence
that maternal antibody idiotypes specific for helminth
antigens can be transferred across the placenta and can
themselves induce sensitization of the foetus in both
animal models (64) and humans (98). In the case of schis-
tosomiasis, studies in mice suggest that, by promoting
IFN-c responses in the neonate, in utero sensitization
down-regulates the (Th2-mediated) granuloma formation
associated with pathology (64).
Non-helminth-specific effects
These possible mechanisms largely provide explanations
for effects of maternal helminth infections on the off-
springs response to the same helminth infection. How
might maternal helminth infection influence the foetal
response to unrelated antigens?
Cross-reactivity between helminth immunogens and
allergens
In the case of allergens, one possibility may be cross-reac-
tivity between helminth antigens and allergens. There are
many structural similarities between allergens and meta-
zoan parasite immunogens (99), and IgE cross-reactivity
has been demonstrated in several cases – for example, in
human subjects, IgE cross-reactivity has been described
between proteins of the nematodes Anisakis Simplex (100)
and A. lumbricoides (101) and the allergen Dermatophago-
ides pteronyssinus; IgE, IgG and IgG4 cross-reactivity has
been demonstrated between filarial antigen and cockroach
allergen (102). IgE cross-reactivity has also been demon-
strated between peanut allergen and schistosome egg anti-
gen in a setting in Ghana where almost no clinical peanut
allergy occurs and this has been shown to be attributable
to cross-reactive carbohydrate determinants, rather than
protein antigens (103). We hypothesize that intrauterine
exposure to cross-reactive parasite immunogens might
result in foetal acquisition of tolerance to allergens, or foe-
tal sensitization to related, parasite-specific IgG idiotypes
might modulate the foetal allergen-specific response to a
nonpathogenic profile.
Effects on innate immune responses
Alternatively, maternal helminth infection might influence
the foetal innate immune system in such a way as to mod-
ulate the response induced on co-exposure to a wide range
of heterologous antigens including malaria, tetanus and
mycobacterial antigen, as well as allergens. Allergologists
have explored this possibility to investigate how prenatal
exposure to a barn environment might influence the
offsprings risk of allergy-related disease. Using a mouse
model of experimental allergic airway inflammation, Con-
rad and colleagues showed that low-grade inflammation in
the maternal lung induced by the cowshed-derived bacte-
rium Acinetobacter lwoffii was associated with reduced
susceptibility to experimentally induced asthma in the off-
spring and that this was mediated by up-regulation of
maternal Toll-like receptor (TLR) expression and circulat-
ing pro-inflammatory cytokines, and down-regulation of
placental TLR expression (104, 105). Helminths also have
systemic effects on circulating inflammatory mediators
and TLR expression and might influence placental and
foetal antigen-presenting cell profiles in a related manner
(106).
CONCLUSION
Helminth infection during pregnancy is common, but the
benefits of anthelminthic treatment during pregnancy are
not yet clear either for the mother or for the offspring.
On the other hand, there is strong epidemiological evi-
dence that prenatal exposure to maternal helminth infec-
tion tends to down-modulate the offsprings response
following infection, resulting in increased susceptibility to
the same helminth species, but reduced pathology. Thus,
an unwanted consequence of partially successful inter-
vention against helminths may be increased susceptibility
to helminth-induced pathology in some endemic settings
as prevalence during pregnancy declines. Of more inter-
est, however, is the increasing evidence that prenatal
exposure to helminths may influence the offsprings sus-
ceptibility to other conditions, and particularly to
allergy-related disease. The mechanisms of this effect
deserve urgent investigation as they may indicate
possible routes to the primary prevention, or manage-
ment, of these conditions.
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